TOC, CQ (Chloroquine), CHX (Cycloheximide) and
MG-132 were purchased from Selleck Chemicals.
3methyladenine (3-MA) and
Z-VAD (Z-Val-Ala-Asp (OMe)-FMK) were purchased from MedChem Express.
Lipofectamine 3000 reagent was purchased from Invitrogen. The antibodies involved in this study were listed as following:
cleaved caspase-3 (9664S; Cell Signaling Technology, Danvers, MA, USA), PARP (ab74290; Abcam, Cambridge, MA, USA),
cleaved PARP (ab32064; Abcam),
LC3 (NB100-2220; Novus, Saint Charles, MO, USA), ATG5 (12994S; Cell Signaling Technology), Akt (4685; Cell Signaling Technology),
phosphorylated (p-)Akt (Ser473) (4060; Cell Signaling Technology), mTOR (2972; Cell Signaling Technology),
p-mTOR (Ser2448) (2971; Cell Signaling Technology),
p70S6K (9202; Cell Signaling Technology), p-
p70S6K (Ser371) (9208; Cell Signaling Technology),
Cyr61 (122190, ZEN BIO), Ki67 (ab66155; Abcam),
β-actin (sc-1616; Santa Cruz Biotechnology), and
horseradish peroxidaseconjugated anti-rabbit secondary antibody (sc-2004; Santa Cruz Biotechnology),
horseradish peroxidaseconjugated anti-mouse secondary antibody (sc-2005; Santa Cruz Biotechnology).
Qiao L., Qin S., Weng N., Li B., Luo M., Zhang Z., Zhou L., Wang D, & Huang C. (2023). Discovery of canine drug toceranib phosphate as a repurposed agent against human hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 43(4).